Lipocine LPCN
NASDAQ LPCN
$1.56 -0.04 (-2.52%)
As of: Oct 22, 2026 · 11:04 AM EDT

Lipocine (LPCN) Long-Term Debt Issuances (2018)

Updated

Lipocine's Long-Term Debt Issuances was $233,537 in FY2020.

Analysis

Lipocine (LPCN) Long-Term Debt Issuances (2018) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $10 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn -
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn -
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn -
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn -
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn -
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn -
10 Lipocine 8.44 Mn -59.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 10.00 Mn
API Access

Lipocine Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=LPCN&period=max&api_key=YOUR_API_KEY